6,6-Dimethyl-1-methoxy-heptan | 59612-34-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 6,6-Dimethyl-1-methoxy-heptan
• 英文别名: 1-methoxy-6,6-dimethyl-heptane；1-Methoxy-6,6-dimethylheptane
• CAS: 59612-34-9
• 化学式: C₁₀H₂₂O
• 分子量: 158.284
• InChiKey: CPDVRNDQNPFVNX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  11
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  5,5-dimethyl-1,3-hexadiene 在 Lindlar's catalyst 氢气 作用下， 生成 6,6-Dimethyl-1-methoxy-heptan
  参考文献：
  名称：

  Shikhmamedbekova,A.Z.; Khudiev,A.C., Journal of Organic Chemistry USSR (English Translation), 1976, vol. 12, p. 328 - 332

  摘要：

  DOI：

文献信息

• NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF
  申请人：S&T Global Inc.

  公开号：US20130210704A1

  公开（公告）日：2013-08-15

  The present invention relates to a compound of the Formula (I)): or pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same, a method for treating or preventing viral infections, inflammation, dry eye, central nervous disorders, cardiovascular diseases, cancer, obesity, diabetes, muscular dystrophy, and hair loss.

  本发明涉及公式(I)的化合物或其药学上可接受的盐，其中符号如规范中所定义；以及包含该化合物的制药组合物，用于治疗或预防病毒感染、炎症、干眼症、中枢神经系统疾病、心血管疾病、癌症、肥胖症、糖尿病、肌肉营养不良和脱发的方法。
• TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME
  申请人：Corsair Pharma, Inc.

  公开号：US20150166503A1

  公开（公告）日：2015-06-18

  Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.

  式子 I、II、III 和 IV 所代表的化合物包括替前列环素和前列环素类似物的前药。用途包括治疗肺高压（PH）或肺动脉高压（PAH）。这些化合物的结构可以根据适当的治疗剂量适应特定的应用。可以使用经皮应用。
• Novel Imidazole Amines as Modulators of Kinase Activity
  申请人：Merck Patent GmbH

  公开号：US20160000785A1

  公开（公告）日：2016-01-07

  The invention provides novel imidazole amine compounds according to Formula (I) and Formula (II) their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.

  本发明提供了根据公式（I）和公式（II）的新型咪唑胺化合物，以及它们的制备和用于治疗高增殖性疾病，如癌症的用途。
• Cyclosporin derivatives and uses thereof
  申请人：S&T Global Inc.

  公开号：US10647747B2

  公开（公告）日：2020-05-12

  The present invention relates to a compound of the Formula (I)): or pharmaceutically acceptable salt thereof, wherein the symbols are as defined in the specification; a pharmaceutical composition comprising the same, a method for treating or preventing viral infections, inflammation, dry eye, central nervous disorders, cardiovascular diseases, cancer, obesity, diabetes, muscular dystrophy, and hair loss.

  本发明涉及一种式 (I)) 的化合物： 或其药学上可接受的盐，其中符号如说明书中所定义；包含该化合物的药物组合物；治疗或预防病毒感染、炎症、干眼症、中枢神经紊乱、心血管疾病、癌症、肥胖症、糖尿病、肌肉萎缩症和脱发的方法。
• Pentacycline Compounds
  申请人：Clark Roger B.

  公开号：US20120115819A1

  公开（公告）日：2012-05-10

  The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I) and its therapeutic use.